Impact of SARS-CoV-2 Preventive Measures against Healthcare-Associated Infections from Antibiotic-Resistant ESKAPEE Pathogens: A Two-Center, Natural Quasi-Experimental Study in Greece
Authors:
- Emmanouil BolikasEBEmmanouil Bolikas
- Eirini AstrinakiEAEirini Astrinaki
- Evangelia PanagiotakiEPEvangelia Panagiotaki
- Efsevia VitsaxakiEVEfsevia Vitsaxaki
- Stamatina SaplamidouSSStamatina Saplamidou
- Ioannis DrositisIDIoannis Drositis
- Dimitra StafylakiDSDimitra Stafylaki
- Georgios ChamilosGCGeorgios Chamilos
- Achilleas GikasAGAchilleas Gikas
- Diamantis P. KofteridisDKDiamantis P. Kofteridis
- Evangelos I. KritsotakisEvangelos I. Kritsotakis
Open Access
- 22 June 2023
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 12 (7) , 1088
Abstract
The COVID-19 pandemic led to unprecedented stress on healthcare systems worldwide, forming settings of concern for increasing antimicrobial resistance. We investigated the impact of SARS-CoV-2 preventive measures against healthcare-associated infections (HAIs) from antibiotic-resistant bacteria in two tertiary-care hospitals. We compared infection rates between March 2019 and February 2020 (pre-intervention period) and March 2020 and February 2021 (COVID-19 intervention period) from drug-resistant ESKAPEE bacteria (methicillin-resistant Staphylococcus aureus; vancomycin-resistant Enterococci; carbapenem-resistant Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species and Escherichia coli). Over 24 months, 586 drug-resistant ESKAPEE HAIs occurred in 439 patients (0.3% of 179,629 inpatients) with a mean age of 63 years, with 43% being treated in intensive care units (ICUs), and having a 45% inpatient mortality rate. Interrupted time series analysis revealed increasing infection rates before the intervention that were sharply interrupted by abrupt drops for most pathogens and henceforth remained stable in the ICUs but progressively increased in ordinary wards. In the ICUs, the pooled infection rate was 44% lower over the intervention period compared to the pre-intervention period (incidence rate ratio (IRR) 0.56, 95%CI 0.41–0.75, p < 0.001). Pooled infection rates in the wards were slightly higher over the COVID-19 period (IRR 1.12, 95%CI 0.87–1.45, p = 0.368). The findings confirmed the ancillary beneficial impact of the enhanced bundle of transmission-based precautions adopted against SARS-CoV-2 in rapidly constraining antimicrobial-resistant HAIs in two Greek hospitals.Keywords
This publication has 35 references indexed in Scilit:
- How to start an antimicrobial stewardship programme in a hospitalClinical Microbiology and Infection, 2020
- Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation2019
- Implementation of multimodal infection control and hand hygiene strategies in acute-care hospitals in Greece: A cross-sectional benchmarking surveyAmerican Journal of Infection Control, 2018
- Temporal trends and patterns in antimicrobial-resistant Gram-negative bacteria implicated in intensive care unit-acquired infections: A cohort-based surveillance study in Istanbul, TurkeyJournal of Global Antimicrobial Resistance, 2018
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisThe Lancet Infectious Diseases, 2018
- Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in GreeceInfection and Drug Resistance, 2017
- Interrupted time series regression for the evaluation of public health interventions: a tutorialInternational Journal of Epidemiology, 2016
- Statistical Analysis and Application of Quasi Experiments to Antimicrobial Resistance Intervention StudiesClinical Infectious Diseases, 2007
- Epidemiological interpretation of antibiotic resistance studies – what are we missing?Nature Reviews Microbiology, 2004
- Improving the Reporting Quality of Nonrandomized Evaluations of Behavioral and Public Health Interventions: The TREND StatementAmerican Journal of Public Health, 2004